# A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.

> **NCT00381394** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 61 (actual)

## Conditions studied

- Leishmaniasis, Visceral

## Interventions

- **DRUG:** sitamaquine

## Key facts

- **NCT ID:** NCT00381394
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08-04
- **Primary completion:** 2007-09-14
- **Final completion:** 2007-09-14
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2017-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00381394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00381394, "A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00381394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*